First Things First

In an industry like ours, doing things in the right order matters.  It does not matter of you are working in the lab, biz dev or the front office.  When you forget to put first things first you might not get the outcome you expect…or need.

At AZBio we have been investing our time in research.  For us that means getting out of the office and into the  community to talk to Members, create opportunities to connect and to listen to what they have to say.  Whether we are are in one-on-one visits to Members and their companies, meetings at the GPEC, The Desert Angels or BCLSA or hanging out with the AZBio Gang at Beer and Bio, we’ve been asking questions and gathering data on what you, our members want and need.   So far this research has led to some new developments and there are a lot more coming,  Here are FIVE important things you said…Continue reading

AZBio News – April and May 2011

Green and lean: Secreting bacteria eliminate cost  barriers for renewable biofuel production

Kinetic Muscles, Inc. Celebrates 10 year anniversary

Yulex names Jim Mitchell COO by Angela Gonzales, Phoenix Business Journal

Laura Gonzalez selected for Phoenix Business Journal’s ‘Forty Under 40’ honors

ISO 13485 Certification Achieved by Regenesis Biomedical

Dr. David Eberhard joins Flagship as Chief Medical Pathologist

University of Minnesota licenses multiplexing software to Flagship Biosciences

AZBio News for March 2011

Apthera and RXi Pharmaceuticals Announce Definitive Merger Agreement

Ventana Medical Launches Virtuoso Software for Digital Pathology

Catalyst for Growth – AZ Bio moves forward with new CEO and an aggressive agenda

Gore Reports First Patient Treated in the U.S. using GORE® VIABAHN® Endoprosthesis with Heparin Bioactive Surface on a Lower Profile Delivery System

MSDx Awarded $226,000 Arizona Commerce Authority Grant

AdvaMed Appoints Regenesis Biomedical Chief Executive to Board of Directors